{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:22:37Z","timestamp":1782706957484,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008451","name":"Binghamton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.expneurol.2025.115497","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:29:36Z","timestamp":1759937376000},"page":"115497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Optimizing L-DOPA treatment through treadmill controlled exercise in a hemi-parkinsonian rat model"],"prefix":"10.1016","volume":"395","author":[{"given":"Shruti","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N'Senga","family":"Kinzonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Galfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizza","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lipari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Budrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115497_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2013.03.039","article-title":"Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice","volume":"243","author":"Aguiar","year":"2013","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0015","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1519\/JPT.0000000000000322","article-title":"Effect of exercise on motor symptoms in patients with Parkinson\u2019s disease: a network meta-analysis","volume":"46","author":"\u00c1lvarez-Bueno","year":"2023","journal-title":"J. Geriatric Phys. Therapy (2001)"},{"key":"10.1016\/j.expneurol.2025.115497_bb0020","article-title":"Getting to compliance in forced exercise in rodents: a critical standard to evaluate exercise impact in aging-related disorders and disease","volume":"90","author":"Arnold","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2025.115497_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.805388","article-title":"Molecular mechanisms and therapeutic strategies for levodopa-induced dyskinesia in Parkinson\u2019s disease: a perspective through preclinical and clinical evidence","volume":"13","author":"Bandopadhyay","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.expneurol.2025.115497_bb0030","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.expneurol.2025.115497_bb0040","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3390\/jcm12134427","article-title":"Levodopa-induced Dyskinesias in Parkinson\u2019s disease: an overview on pathophysiology, clinical manifestations, therapy management strategies and future directions","volume":"12","author":"di Biase","year":"2023","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115497_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.31083\/j.jin2312221","article-title":"Coherent changes in neural motor network activity during levodopa-induced Dyskinesia in a rat model of Parkinson\u2019s disease","volume":"23","author":"Brazhnik","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115497_bb0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/cells12060837","article-title":"Broad serotonergic actions of vortioxetine as a promising avenue for the treatment of L-DOPA-induced dyskinesia","volume":"12","author":"Budrow","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2025.115497_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-0179-4-1","article-title":"Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder","volume":"4","author":"Carta","year":"2008","journal-title":"Clin. Pract. Epidemiol. Mental Health: CP & EMH"},{"key":"10.1016\/j.expneurol.2025.115497_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102833","article-title":"Cells, pathways, and models in dyskinesia research","volume":"84","author":"Cenci","year":"2024","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.27959","article-title":"Dyskinesia matters","volume":"35","author":"Cenci","year":"2020","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115497_bib453","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1111\/ejn.15106","article-title":"Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats","volume":"53","author":"Chambers","year":"2021","journal-title":"The European journal of neuroscience"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2025.115497_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.20279","article-title":"Impact of the motor complications of Parkinson\u2019s disease on the quality of life","volume":"20","author":"Chapuis","year":"2005","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.WNL.0000151960.28687.93","article-title":"Physical activity and the risk of Parkinson disease","volume":"64","author":"Chen","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.expneurol.2025.115497_bb0090","first-page":"747","article-title":"Long-term levodopa therapy and the risk of levodopa-induced dyskinesia in Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2010","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115497_bb0100","first-page":"1200","article-title":"Aerobic exercise improves motor symptoms and modulates dyskinesia in Parkinson\u2019s disease: a randomized controlled trial","volume":"35","author":"Choi","year":"2020","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115497_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141898","article-title":"Running reduces uncontrollable stress-evoked serotonin and potentiates stress-evoked dopamine concentrations in the rat dorsal striatum","volume":"10","author":"Clark","year":"2015","journal-title":"PloSone"},{"key":"10.1016\/j.expneurol.2025.115497_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173393","article-title":"The multimodal serotonin compound vilazodone alone, but not combined with the glutamate antagonist amantadine, reduces L-DOPA-induced dyskinesia in hemiparkinsonian rats","volume":"217","author":"Cohen","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"16","key":"10.1016\/j.expneurol.2025.115497_bb0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.expneurol.2025.115497_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","article-title":"Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats","volume":"77","author":"Conti","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115497_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.pbr.2021.01.032","article-title":"Serotonin\/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: an update","volume":"261","author":"Corsi","year":"2021","journal-title":"Prog. Brain Res."},{"issue":"s1","key":"10.1016\/j.expneurol.2025.115497_bb0150","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115497_bb0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinsondisease: Current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115497_bb0175","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00221-024-06897-6","article-title":"Cognitive reserve and executive functions in dual task gait performance in Parkinson\u2019s disease","volume":"242","author":"Fern\u00e1ndez-Lago","year":"2024","journal-title":"Exp. Brain Res."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bib455","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/NRE-2012-0758","article-title":"Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatments","volume":"30","author":"Frazzitta","year":"2012","journal-title":"NeuroRehabilitation"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1545968314542981","article-title":"Intensive rehabilitation treatment in early Parkinson\u2019s disease: a randomized pilot study with a 2-year follow-up","volume":"29","author":"Frazzitta","year":"2015","journal-title":"Neurorehabil. Neural Repair"},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","article-title":"A subpopulation of striatal neurons mediates levodopa-induced Dyskinesia","volume":"97","author":"Girasole","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115497_bb0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mds.21922","article-title":"The effectiveness of exercise interventions for people with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"23","author":"Goodwin","year":"2008","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1474-4422(13)70025-5","article-title":"Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson\u2019s disease and motor fluctuations: a phase 3 randomised, double-blind trial","volume":"12","author":"Hauser","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2025.115497_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114563","article-title":"The effects of L-DOPA on gait abnormalities in a unilateral 6-OHDA rat model of Parkinson's disease","volume":"281","author":"Holden","year":"2024","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115497_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114875","article-title":"Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned rats and reduces serum levels of biomarkers of Parkinson\u2019s disease severity without recovery of striatal dopamine or tyrosine hydroxylase","volume":"379","author":"Kasanga","year":"2024","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4103\/NRR.NRR-D-23-00595","article-title":"Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson\u2019s disease","volume":"20","author":"Kerdiles","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"23","key":"10.1016\/j.expneurol.2025.115497_bb0225","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.3390\/cells11233736","article-title":"Levodopa-induced Dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies","volume":"11","author":"Kwon","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-024-00641-1","article-title":"Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson\u2019s disease","volume":"10","author":"de Laat","year":"2024","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115497_bb0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00702-017-1837-1","article-title":"Serotonergic targets for the treatment of L-DOPA-induced dyskinesia","volume":"125","author":"Lanza","year":"2018","journal-title":"J. Neural. Trans. (Vienna, Austria: 1996)"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0240","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/biomedicines9030314","article-title":"Dopamine D3 receptor plasticity in Parkinson's disease and L-DOPA-induced Dyskinesia","volume":"9","author":"Lanza","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14823-5","article-title":"Neurogenic effects of rotarod walking exercise in subventricular zone, subgranular zone, and substantia nigra in MPTP-induced parkinson\u2019s disease mice","volume":"12","author":"Leem","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0255","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/jpet.111.179416","article-title":"Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat","volume":"337","author":"Lindenbach","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"28","key":"10.1016\/j.expneurol.2025.115497_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh1403","article-title":"Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity","volume":"9","author":"Marino","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2025.115497_bb0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson\u2019s disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1249\/JES.0000000000000111","article-title":"Exercise is medicine, but does it interfere with medicine?","volume":"45","author":"McLaughlin","year":"2017","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115497_bb0280","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/mds.100","article-title":"Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats","volume":"33","author":"Meadows","year":"2018","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115497_bb0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","article-title":"The \u2018magic\u2019 of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy?","volume":"26","author":"Mercuri","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/mds.21346","article-title":"Exercise improves efficacy of levodopa in patients with Parkinson's disease","volume":"22","author":"Muhlack","year":"2007","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"key":"10.1016\/j.expneurol.2025.115497_bib451","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115497_bb0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrn1970","article-title":"Enriched environments, experience-dependent plasticity and disorders of the nervous system","volume":"7","author":"Nithianantharajah","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bib454","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1123\/JAPA.2013-0107","article-title":"Spin exercise improves semantic fluency in previously sedentary older adults","volume":"23","author":"Nocera","year":"2015","journal-title":"Journal of aging and physical activity"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115497_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JPD-239001","article-title":"Clinical trial highlights - interventions promoting physical activity in Parkinson\u2019s disease","volume":"13","author":"Oosterhof","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115497_bb0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.03.008","article-title":"Modulation of L-DOPA\u2019s antiparkinsonian and dyskinetic effects by \u03b12-noradrenergic receptors within the locus coeruleus","volume":"95","author":"Ostock","year":"2015","journal-title":"Neuropharmacology"},{"issue":"Pt 4","key":"10.1016\/j.expneurol.2025.115497_bb0315","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain J. Neurol."},{"issue":"7704","key":"10.1016\/j.expneurol.2025.115497_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","article-title":"Diametric neural ensemble dynamics in parkinsonian and dyskinetic states","volume":"557","author":"Parker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115497_bb0330","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2006"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115497_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JPD-2012-12077","article-title":"Effects of levodopa on vividness of motor imagery in Parkinson disease","volume":"2","author":"Peterson","year":"2012","journal-title":"J. Parkinsons Dis."},{"issue":"20","key":"10.1016\/j.expneurol.2025.115497_bb0340","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1523\/JNEUROSCI.1069-07.2007","article-title":"Effects oftreadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"27","author":"Petzinger","year":"2007","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115497_bb0345","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","article-title":"Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease","volume":"12","author":"Petzinger","year":"2013","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0350","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"323","author":"Putterman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115497_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114483","article-title":"Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input","volume":"43","author":"Ryan","year":"2024","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115497_bb0365","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3233\/JPD-223157","article-title":"Establishing equivalent aerobic exercise parameters between early-stage Parkinson\u2019s disease and Pink1 knockout rats","volume":"12","author":"Salvatore","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0370","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3233\/JPD-202247","article-title":"Barriers and motivators to engage in exercise for persons with Parkinson\u2019s disease","volume":"10","author":"Schootemeijer","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bib452","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-018-0653-7","article-title":"Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia","volume":"7","author":"Sellnow","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0380","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12984-016-0185-y","article-title":"Effects of a balance-based exergaming intervention using the Kinect sensor on posture stability in individuals with Parkinson\u2019s disease: a single-blinded randomized controlled trial","volume":"13","author":"Shih","year":"2016","journal-title":"J. Neuroeng. Rehabil."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115497_bb0390","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00213-022-06078-9","article-title":"The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats","volume":"239","author":"Smith","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/npp.2011.212","article-title":"Parkinson\u2019s disease therapeutics: new developments and challenges since the introduction of levodopa","volume":"37","author":"Smith","year":"2012","journal-title":"Neuropsychopharmacol.: Off. Public. Am. College Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0400","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s12035-018-1278-3","article-title":"Treadmill exercise Attenuates L-DOPA-Induced Dyskinesia and increases striatal levels of glial cell-derived neurotrophic factor (GDNF) in Hemiparkinsonian mice","volume":"56","author":"Speck","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0405","first-page":"R541","article-title":"Exercise decreases aberrant corticostriatal plasticity in an animal model of l-DOPA-induced dyskinesia","volume":"320","author":"Speck","year":"2021","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.expneurol.2025.115497_bb0410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2012.09.063","article-title":"Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson\u2019s disease","volume":"227","author":"Tuon","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2025.115497_bb0415","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainresbull.2014.09.006","article-title":"Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson\u2019s disease","volume":"108","author":"Tuon","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2025.115497_bb0420","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2013.12.014","article-title":"Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia","volume":"64","author":"Ueno","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.expneurol.2025.115497_bb0425","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/mds.23407","article-title":"Exercise elevates dopamine D2 receptor in a mouse model of Parkinson\u2019s disease: in vivo imaging with [18F]fallypride","volume":"25","author":"Vu\u010dkovi\u0107","year":"2010","journal-title":"Move. Disord.: Off. J. Move. Disord. Soc."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0430","doi-asserted-by":"crossref","first-page":"31167","DOI":"10.1038\/s41598-024-82470-z","article-title":"Multi-omics analysis reveals the genetic aging landscape of Parkinson's disease","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115497_bb0435","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.0b013e3181ea1597","article-title":"Physical activities and future risk of Parkinson disease","volume":"75","author":"Xu","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115497_bb0440","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1038\/s41598-023-32480-0","article-title":"Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson\u2019s disease biomarkers using multiplexed single molecule counting","volume":"13","author":"Youssef","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115497_bb0445","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2012.12.011","article-title":"Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat","volume":"70","author":"Zengin-Toktas","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115497_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.935176","article-title":"Effectiveness of aerobic and resistance training on the motor symptoms in Parkinson's disease: systematic review and network meta-analysis","volume":"14","author":"Zhou","year":"2022","journal-title":"Front. Aging Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625003620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625003620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:14:34Z","timestamp":1780474474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":82,"alternative-id":["S0014488625003620"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115497","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing L-DOPA treatment through treadmill controlled exercise in a hemi-parkinsonian rat model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115497"}}